Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 IV MR11A8 (interferon beta-1a) in moderate to severe ARDS
jRCT2080222665Phase 2
- Sponsor
- Maruishi Pharmaceutical Co., Ltd.
- Start
- Nov 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of interferon beta-1a in acute respiratory distress syndrome (ARDS) (3 arms), sponsored by Maruishi Pharmaceutical Co., Ltd.
02
Drugs
interferon beta-1a
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on jRCT2080222665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222665.